Nkarta (NKTX) Cash from Investing Activities (2019 - 2026)

Nkarta's quarterly Cash from Investing Activities came in at $15.9 million in Q1 2026, down 70.71% year-on-year from $54.3 million in Q1 2025, and up 1342.88% quarter-over-quarter from $1.1 million in Q4 2025.

Nkarta has reported Cash from Investing Activities for 8 years, with the latest figure at $15.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 70.71% year-over-year to $15.9 million; the trailing twelve-month figure through Mar 2026 stood at $61.9 million (up 164.01% YoY), and the FY2025 full-year result was $100.3 million, up 177.43% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $15.9 million, up from $1.1 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $54.3 million in Q1 2025, with the low at -$109.3 million in Q2 2022.
  • Average Cash from Investing Activities over 5 years is -$7.0 million, with a median of $4.7 million recorded in 2022.
  • Year-over-year, Cash from Investing Activities jumped 3699.32% in 2023 and plunged 3294.04% in 2024.
  • Tracing NKTX's Cash from Investing Activities over 5 years: stood at $4.7 million in 2022, then jumped by 233.62% to $15.8 million in 2023, then sank by 128.54% to -$4.5 million in 2024, then jumped by 124.4% to $1.1 million in 2025, then soared by 1342.88% to $15.9 million in 2026.
  • The last three Cash from Investing Activities figures came in at $15.9 million (Q1 2026), $1.1 million (Q4 2025), and $25.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -2.89 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 638.50 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -431.90 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -428.90 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -25.54 Mn
10 Nkarta 232.80 Mn 232.80 Mn - 15.92 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 15.92 Mn
Mar 31, 2026 15.92 Mn
Dec 31, 2025 1.10 Mn
Dec 31, 2025 1.10 Mn
Sep 30, 2025 25.39 Mn
Sep 30, 2025 25.39 Mn
Jun 30, 2025 19.49 Mn
Jun 30, 2025 19.49 Mn
Mar 31, 2025 54.34 Mn
Mar 31, 2025 54.34 Mn
Dec 31, 2024 -4.52 Mn
Dec 31, 2024 -4.52 Mn
Sep 30, 2024 -38.90 Mn
Sep 30, 2024 -38.90 Mn
Jun 30, 2024 -107.63 Mn
Jun 30, 2024 -107.63 Mn
Mar 31, 2024 21.49 Mn
Mar 31, 2024 21.49 Mn
Dec 31, 2023 15.84 Mn
Dec 31, 2023 15.84 Mn
Sep 30, 2023 29.42 Mn
Sep 30, 2023 29.42 Mn
Jun 30, 2023 -3.17 Mn
Jun 30, 2023 -3.17 Mn
Mar 31, 2023 36.93 Mn
Mar 31, 2023 36.93 Mn
Dec 31, 2022 4.75 Mn
Dec 31, 2022 4.75 Mn
Sep 30, 2022 -79.11 Mn
Sep 30, 2022 -79.11 Mn
Jun 30, 2022 -109.30 Mn
Jun 30, 2022 -109.30 Mn
Mar 31, 2022 -1.03 Mn
Mar 31, 2022 -1.03 Mn
Dec 31, 2021 -17.84 Mn
Dec 31, 2021 -17.84 Mn
Sep 30, 2021 91.51 Mn
Sep 30, 2021 91.51 Mn
Jun 30, 2021 -20.95 Mn
Jun 30, 2021 -20.95 Mn
Mar 31, 2021 -20.19 Mn
Mar 31, 2021 -20.19 Mn
Dec 31, 2020 -78.72 Mn
Dec 31, 2020 -78.72 Mn
Sep 30, 2020 -139.07 Mn
Sep 30, 2020 -139.07 Mn
Jun 30, 2020 2.81 Mn
Jun 30, 2020 2.81 Mn
Mar 31, 2020 4.90 Mn
Mar 31, 2020 4.90 Mn
Dec 31, 2019 -16.99 Mn
Dec 31, 2019 -16.99 Mn
Sep 30, 2019 -601,199.00
Sep 30, 2019 -601,199.00